Key terms

About PRGO

Perrigo Co. Plc engages in the provision of self-care products and over the counter health and wellness solutions. It enhances individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. It operates through the Consumer Self-Care Americas and Consumer Self-Care International segments. The Consumer Self-Care Americas segment offers OTC solutions, infant formula, oral care, and contract manufacturing in the U.S, Mexico, and Canada. The Consumer Self-Care International segment includes the self-care business branded in Europe, Australia, the United Kingdom, and parts of Europe and Asia. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest PRGO news

Apr 08 7:25am ET Perrigo’s Game-Changing Opill Gains Groundbreaking CVS Coverage: A Buy Rating Endorsement Apr 08 6:42am ET Perrigo price target raised to $39 from $35 at Piper Sandler Apr 05 6:47am ET Piper Sandler Remains a Buy on Perrigo Company (PRGO) Apr 04 2:50pm ET CVS to cover Perrigo birth control drug at no cost, Bloomberg reports Apr 04 1:12pm ET Perrigo recent pullback a buying opportunity, says Argus Mar 14 7:16am ET Perrigo’s Strategic Shift to Self-Care and Infant Formula Sector Poised for Growth Beyond 2024 Mar 12 7:40am ET 5 Stocks Corporate Insiders are Buying in March 2024 Mar 06 5:04pm ET Erica Mann Retires from Perrigo Board After Influential Tenure Mar 04 8:16am ET Perrigo commences shipments of Opill Mar 03 4:52am ET Ex-Dividend Date Nearing for These 10 Stocks – Week of March 4, 2024 Feb 28 7:16am ET Perrigo price target lowered to $42 from $49 at Canaccord Feb 27 12:00pm ET Perrigo falls -16.0% Feb 27 10:00am ET Perrigo falls -13.6% Feb 27 9:47am ET Perrigo falls -15.2% Feb 27 6:39am ET Perrigo sees FY24 adjusted EPS $2.50-$2.65, consensus $2.99 Feb 27 6:37am ET Perrigo reports Q4 adjusted EPS 86c, consensus 83c Feb 26 4:31pm ET Perrigo increases quarterly dividend 1% Feb 12 8:45am ET Largest borrow rate increases among liquid names Jan 12 7:37am ET Piper Sandler Remains a Buy on Perrigo Company (PRGO)

No recent press releases are available for PRGO

PRGO Financials

1-year income & revenue

Key terms

PRGO Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

PRGO Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms